KRAS and neoplasm: On the other hand, NCDB provides detailed information on tumor characteristics and treatment aspects not available in SEER, such as microsatellite instability, KRAS mutations, palliative care details, unplanned hospital readmissions, and 30‐day mortality rates following surgery.